ELUT Elutia Inc.
$0.90
Elutia Inc. (ELUT) Earnings News
Earnings press releases, previews and reviews for Elutia Inc. (ELUT), newest first. Our most recent is review: Elutia's Loss Deepens as NXT-41x R&D Ramps, but Q3 Was About De-Risking: GLP Study Win, $26 Million Non-Dilutive Funding, and a Q4 FDA Filing.
Thursday
November 5, 2026
9:21 PM ET
Elutia's Loss Deepens as NXT-41x R&D Ramps, but Q3 Was About De-Risking: GLP Study Win, $26 Million Non-Dilutive Funding, and a Q4 FDA Filing
Earnings Whispers · Review
Thursday
November 5, 2026
4:17 PM ET
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
Thursday
October 22, 2026
4:05 PM ET
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Thursday
August 13, 2026
4:10 PM ET
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
Friday
July 31, 2026
8:00 AM ET
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026